PFE · News · 20260919N
Acquisition / Partnership / Divestiture
PFIZER INC · 2026-09-19 · Importance 40 · Surprise 42 · In source text
Novartis India acquired Pfizer’s Minipress and Minipress (prazosin) trademarks and related intellectual property rights in India for USD 150 million. The transaction gives Novartis India full ownership of the brands in India’s hypertension market. Pfizer is divesting the mature, non-core asset to focus on newer products.
Key facts
- Novartis India acquired the Minipress and Minipress (prazosin) trademarks and related intellectual property rights in India from Pfizer for USD 150 million. source
- Pfizer's sale of the Minipress brands to Novartis India is described as a strategic divestment of a mature, non-core asset to focus on newer products. source
- Pfizer's stock quote in the digest: PFE +0.07%. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | committed | +0.1% | Novartis India acquired the Minipress and Minipress (prazosin) trademarks and related intellectual property rights in India from Pfizer… |
| assets | negative | committed | — | Novartis India acquired the Minipress and Minipress (prazosin) trademarks and related intellectual property rights in India from Pfizer… |